Lu Z - Search Results

1

OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.

Peng KZ, Ke Y, Zhao Q, Tian F, Liu HM, Hou G, Lu Z. Peng KZ, et al. Among authors: lu z. Biochem Pharmacol. 2017 Sep 15;140:16-27. doi: 10.1016/j.bcp.2017.05.013. Epub 2017 May 21. Biochem Pharmacol. 2017. PMID: 28539264

2

Mutational analysis of the PTEN gene and its effects in esophageal squamous cell carcinoma.

Hou G, Lu Z, Liu M, Liu H, Xue L. Hou G, et al. Among authors: lu z. Dig Dis Sci. 2011 May;56(5):1315-22. doi: 10.1007/s10620-010-1474-0. Epub 2010 Nov 30. Dig Dis Sci. 2011. PMID: 21116717

3

[Sensitivity of esophageal squamous cell carcinoma cells to rapamycin can be improved by siRNA-interfered expression of p70S6K].

Liu M, Lu Z, Zheng Y, Cui Y, Wang J, Hou G. Liu M, et al. Among authors: lu z. Zhonghua Zhong Liu Za Zhi. 2015 Dec;37(12):885-9. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26887615 Chinese.

4

Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma.

Lu Z, Peng K, Wang N, Liu HM, Hou G. Lu Z, et al. J Immunol Res. 2016;2016:7828916. doi: 10.1155/2016/7828916. Epub 2016 Aug 9. J Immunol Res. 2016. PMID: 27595116 Free PMC article.

5

Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma.

Hou G, Zhao Q, Zhang M, Fan T, Liu M, Shi X, Ren Y, Wang Y, Zhou J, Lu Z. Hou G, et al. Among authors: lu z. Biomed Pharmacother. 2018 Oct;106:1348-1356. doi: 10.1016/j.biopha.2018.07.075. Epub 2018 Jul 23. Biomed Pharmacother. 2018. PMID: 30119206

6

FLI-06 suppresses proliferation, induces apoptosis and cell cycle arrest by targeting LSD1 and Notch pathway in esophageal squamous cell carcinoma cells.

Lu Z, Ren Y, Zhang M, Fan T, Wang Y, Zhao Q, Liu HM, Zhao W, Hou G. Lu Z, et al. Biomed Pharmacother. 2018 Nov;107:1370-1376. doi: 10.1016/j.biopha.2018.08.140. Epub 2018 Aug 31. Biomed Pharmacother. 2018. PMID: 30257352

7

OP16 induces deadly autophagy and apoptosis of cells by inhibiting Akt in esophageal squamous cell carcinoma.

Hou G, Jia A, Yang L, Zhao Y, Hu Y, Zhao W, Zhao W, Liu HM, Lu Z. Hou G, et al. Among authors: lu z. Mol Cell Biochem. 2020 Sep;472(1-2):219-230. doi: 10.1007/s11010-020-03800-z. Epub 2020 Jul 15. Mol Cell Biochem. 2020. PMID: 32671513

8

mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma.

Lu Z, Zhang Y, Xu Y, Wei H, Zhao W, Wang P, Li Y, Hou G. Lu Z, et al. Mol Biol Rep. 2022 Jan;49(1):451-461. doi: 10.1007/s11033-021-06895-9. Epub 2021 Nov 3. Mol Biol Rep. 2022. PMID: 34731371

9

An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.

Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. Hou G, et al. Among authors: lu z. Cancer Lett. 2007 Aug 18;253(2):236-48. doi: 10.1016/j.canlet.2007.01.026. Epub 2007 Mar 13. Cancer Lett. 2007. PMID: 17360108

10

Targeted inhibition of mTOR signaling improves sensitivity of esophageal squamous cell carcinoma cells to cisplatin.

Hou G, Yang S, Zhou Y, Wang C, Zhao W, Lu Z. Hou G, et al. Among authors: lu z. J Immunol Res. 2014;2014:845763. doi: 10.1155/2014/845763. Epub 2014 Apr 10. J Immunol Res. 2014. PMID: 24818169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,550 results

Search Page

Filters